Texas HB2528 mandates health benefit plans to cover medication-assisted treatment for opioid and substance use disorders without prior authorization.

HB2528 amends the Texas Insurance Code to require health benefit plans to cover medication-assisted treatment for opioid and substance use disorders, defined as the use of methadone, buprenorphine, buprenorphine/naloxone, or naltrexone. The bill applies to various health benefit plans, including those issued by insurance companies, health maintenance organizations, and pharmacy benefit managers. It prohibits these plans from requiring prior authorization for such treatments, except to prevent fraud, waste, and abuse.

Texas HB2528 mandates health benefit plans to cover medication-assisted treatment for opioid and substance use disorders without prior authorization.

HB2528 amends the Texas Insurance Code to require health benefit plans to cover medication-assisted treatment for opioid and substance use disorders, defined as the use of methadone, buprenorphine, buprenorphine/naloxone, or naltrexone. The bill applies to various health benefit plans, including those issued by insurance companies, health maintenance organizations, and pharmacy benefit managers. It prohibits these plans from requiring prior authorization for such treatments, except to prevent fraud, waste, and abuse.